Calquence
Astra Zeneca’s Calquence is an oral cancer medication for chronic lymphocytic leukemia and mantle cell lymphoma.
Calquence’s capabilities target a specific protein that helps certain blood cancer cells grow. By blocking this protein, it slows or stops the cancer’s progression.
My role as the Group Art Supervisor allowed me to discuss design decisions with
clients and oversee the day to day functions of the art and design throughout
collateral and digital.
Brochure design
Drug reps are the engine that gets the information out into the hands of oncologists. Printed pieces combined with digital brochures impact opinions doctors have about any kind of drug. With printed brochures, it becomes imperative to create clean and simple design to get the message of Calquence’s breathrough treatment to doctors.
They can be multi page booklets or 1 page double sided depending on campaign needs. New brand guidelines continue to evolve thus dictating how design becomes executed.
10-page Phase 3 Trial Data Brochure
with rep card and QR Code.
8-page Phase 3 Trial PFS Comparison Brochure
Double Sided Mantle Cell Lymphoma (MCL) Sales Sheet
The LV-004 Drug Trial Results Comparison Sheet
